Navigation Links
Potential Silver Bullet for Swine Flu and Most Common Infections Using Green Technology Patented in U.S. and Mexico
Date:6/24/2009

FORT LAUDERDALE, Fla., June 24 /PRNewswire/ -- Argentech, Inc. (www.argentechinc.com) today announced that it reached agreement with Invision International Health Solutions, Inc., to purchase the rights to Opti-Silver, a patented antibacterial and antiviral technology that utilizes ionic silver in a unique complex for optimal delivery in the human body. The complex was granted broad patent protection in the U.S. and, recently, in Mexico as well. It also has patent protection overseas. (See www.silver100.com/patents.)

Recently, there has been a surge in the number of industrial and medically related products utilizing ionic silver, owing to its broad-spectrum antibacterial and antiviral qualities. University studies and regulatory approvals further attest to the antimicrobial powers of ionic silver, which is harmless to humans with normal use.

The mechanism of action by which ionic silver kills germs gives it this remarkable combination of characteristics. However, it's extremely unstable and requires a delivery mechanism to function.

The result of more than a million dollars in development, Opti-Silver was designed explicitly to optimize the delivery of silver ions in the human body.

"The Opti-Silver complex represents a quantum leap in utilizing ionic silver for internal human use," said Roger Leblanc, Ph.D., former director of the Departments of Chemistry and Advanced Microscopy at the University of Miami. "Nothing else even comes close to the efficiency of its unique delivery mechanism."

Donald Baird, Ph.D., former director of the Department of Chemistry at Florida Atlantic University, has called Opti-Silver "ingenious" and "unprecedented." (See www.silver100.com/reports.)

In November of 2007, the maker of a certain surface disinfectant was granted EPA approval to claim that its ionic silver product kills strains of SARS, Bird Flu, MRSA, influenza, and a range of other pathogens. Drs. Leblanc and Baird have written pointed reports stating that that surface disinfectant would be all but useless for internal human use, citing its lack of an appropriate delivery mechanism for the challenging electro-chemical environment of the human body.

"To a chemist," Dr. Baird stated, "Opti-Silver represents a brilliant chemical formulation that results in a far more efficient delivery mechanism for releasing silver ions in the body than has ever existed before."

"We have the technology and patents to support a business model that enables us to perform serious humanitarian work, by growing our business," said Jay Newman, CEO of Argentech. "And we have a game plan in place to roll this out to the public on a massive scale in a remarkably short time," he said.

A study has been designed, to be conducted at the world's largest clinical research center for pediatric drugs, which Argentech believes will prove the ability of ionic silver to prevent the vast majority of upper respiratory infections, including those that are viral in nature. Fighting viral infection is an area where solutions are still lacking and vitally needed.

"To fund the study, we're relying on wealthy individuals who really want to make a difference in human health on a worldwide scale," Newman said.

"It's not that we mind sharing stock with investors," he added. "We find that philanthropists tend to resonate far better with us, because they share the humanitarian priority behind our mission. It's not just about the numbers for us. It's both. We have to be successful to get this vital product to the people."

Charitable contributions can be made into a 501(C)(3) called the Foundation for Health Research, which will fund the study.

Meet Newman and hear the story at www.argentechinc.com/video1.

This release was issued on behalf of the above organization by Send2Press(R), a unit of Neotrope(R). http://www.Send2Press.com


'/>"/>
SOURCE Argentech, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. DNA vaccine against multiple sclerosis appears safe, potentially beneficial
2. UCLA study identifies designer estrogen as potential MS drug
3. Office-Based Medical Treatment and Internet Resources Are Potential Solution to Rising Painkiller Misuse Among Teens, Young Adults
4. Common abdominal pain may be due to a potentially treatable newly recognized inflammatory reaction
5. Potential new approach to treat cognitive impairments in schizophrenia
6. Nosespray vaccine using aloe vera has exciting potential, researcher says
7. Network approach identifies potential breast cancer susceptibility gene
8. Liver fibrosis will be treated by a potential target
9. Researchers study potential health benefits of natural chemicals in muscadine grape seeds
10. Jefferson researchers find stem cells in degenerating spinal discs, potential for repair
11. China Holdings, Inc. Announces 2nd Biomass Renewable Energy Project (Power Capacity: 50 MW); Total Potential: 100 MW in Biomass Energy Pipeline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for professional women, ... towards gender equality at their inaugural Summit in New York City in June. The ... social audience of over 3 million. To watch the Mobilize Women video, click ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to the Mission ... lost souls in the Philippines. “The Journey: From the Mountains to the Mission Field” ... the Bible. She has taught all ages and currently teaches a class of ladies ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has ... today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula ... the highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. ... recently contributed a medical article to the newly revamped Cosmetic Town journal ... spotlights the hair transplant procedure known as Follicular Unit Extraction (FUE). ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... nation's first interactive health literacy software tool, and the Cancer Patient Education Network ... cancer patient education, today announce a new strategic alliance. , As CPEN’s ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will host ... webcast on Friday, November 3, 2017, beginning at 7:00 ... approximately 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... performance and guidance for 2018, Hill-Rom executives will also ... performance, and long-range financial outlook through 2020. ...
(Date:9/25/2017)... AMSTERDAM , Sept. 25, 2017   ... Trial Master File solutions, today—from the IQPC Trial ... Amsterdam , NL)—announced that EastHORN Clinical Services ... its clinical programs and TMF management. EastHORN, a ... Montrium,s eTMF platform to increase transparency to enable ...
(Date:9/22/2017)... Sept. 22, 2017 AVACEN Medical (AVACEN) announced ... now successfully helping those with the widespread pain associated ... diagnosed Amanda in Essex, England ... my hair, experiencing no sleep at all, tremendous pain, ... I cannot recommend [the AVACEN 100] enough, how this ...
Breaking Medicine Technology: